NeoDynamics announces changes to board of directors
NeoDynamics today announces that Jie Bao and Xiaojun Xu will step down from the Board of Directors as of 2023-02-14 based on a mutual agreement. They will instead focus on supporting the company and its plans for the Chinese market.
The Board will subsequently consist of Ingrid Salén (Chairperson), Carina Bolin, Claes Petterson, and Matthew E. Colpoys, Jr.
“I would like to thank Jie Bao and Xiaojun Xu for their valuable contributions to the Board of Directors of NeoDynamics. I am pleased that they will continue supporting our plans for the Chinese market”, said Chairperson of the Board of Directors, Ingrid Salén.
Read here: https://www.neodynamics.com/sv-se/tools/GetCisionNews?id=4466513&lang=eng
HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 9:10 AM 02-15-2022.
Neodynamics
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Read more on company page